Newsletter | July 27, 2020

07.27.20 -- Strategies For Operational Intelligence In Pharmaceutical Manufacturing

More Than Just Technology: A Holistic Approach To Pharma 4.0

The paradigm shift in today’s pharmaceutical industry that has changed the focus from large-scale production blockbuster drugs to niche drugs for smaller patient populations is increasing the need for manufacturers to improve their operational efficiency and flexibility. This transformation to Pharma 4.0 comes through small steps that are all business-oriented and driven but merge together over time through a technical platform that uses data to connect people and resources.

Implementing Review-By-Exception RtReports For Manufacturing At BioMarin

BioMarin Pharmaceutical — a company focused on developing and manufacturing therapeutics for patients with rare genetic diseases — faced a common industry issue: batch release pressure. In streamlining its batch review process, BioMarin reduced burdens on both its quality assurance and engineering teams while simultaneously speeding time-to-market for its products.

Breaking Down Pharma’s Silos For The Sake Of Data Integrity

The importance of data in pharmaceutical manufacturing cannot be overstated. As the pharmaceutical industry strives to make a digital transformation through connected data, companies must figure out how to effectively use and share their insights with other stakeholders across their networks.